← Eichor
Study identifier: NCT05868161 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Pounce™ Thrombectomy System Retrospective Registry

Condition: Peripheral Arterial Disease · Acute Limb Ischemia  ·  Sponsor: SurModics, Inc.

PhaseN/A
Planned participants500
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The PROWL registry is an open-label retrospective, multi-center, US study of the Surmodics™ Pounce™ Thrombectomy System for the non-surgical removal of emboli and thrombi in the peripheral arterial vasculature.

This description comes directly from the study's public registry record.

Talk to the study team

Clinical Program Manager  ·  1-866-787-6639  ·  PROWLRegistry@surmodics.com

Always discuss trial participation with your own doctor first.

Locations (9)

OSF St. Francis Medical CenterPeoria, Illinois, United StatesRecruiting
Community HospitalMunster, Indiana, United StatesCompleted
Baton Rouge General Medical CenterBaton Rouge, Louisiana, United StatesRecruiting
Allina HealthMinneapolis, Minnesota, United StatesCompleted
Cleveland ClinicCleveland, Ohio, United StatesRecruiting
Prisma Health UpstateGreenville, South Carolina, United StatesRecruiting
North Central HeartSioux Falls, South Dakota, United StatesRecruiting
Vanderbilt University Medical CenterNashville, Tennessee, United StatesRecruiting
Ascension SetonAustin, Texas, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05868161